These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29044160)

  • 21. Exhaled Hydrogen Sulfide Predicts Airway Inflammation Phenotype in COPD.
    Zhang J; Wang X; Chen Y; Yao W
    Respir Care; 2015 Feb; 60(2):251-8. PubMed ID: 25336529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between blood eosinophils and clinical outcome of acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Liu H; Xie Y; Huang Y; Luo K; Gu Y; Zhang H; Xu Y; Chen X
    Respir Med; 2024 Feb; 222():107501. PubMed ID: 38104787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence and clinical characteristics of blood eosinophilia in patients with acute exacerbation of chronic obstructive pulmonary disease].
    Zeng QL; Wang XM; Li SN; Xiong B; Jian M; Huang G; Wu YQ; Wang XH; Li J; Wen FQ; Zhou H
    Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(40):3166-3170. PubMed ID: 29081164
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
    Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
    Lung; 2006; 184(4):217-22. PubMed ID: 17006748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.
    Mentz RJ; Fiuzat M; Wojdyla DM; Chiswell K; Gheorghiade M; Fonarow GC; O'Connor CM
    Eur J Heart Fail; 2012 Apr; 14(4):395-403. PubMed ID: 22302663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
    Siva R; Green RH; Brightling CE; Shelley M; Hargadon B; McKenna S; Monteiro W; Berry M; Parker D; Wardlaw AJ; Pavord ID
    Eur Respir J; 2007 May; 29(5):906-13. PubMed ID: 17301099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.
    Sehmi R; Smith SG; Kjarsgaard M; Radford K; Boulet LP; Lemiere C; Prazma CM; Ortega H; Martin JG; Nair P
    Clin Exp Allergy; 2016 Jun; 46(6):793-802. PubMed ID: 26685004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eosinophilic Chronic Obstructive Pulmonary Disease.
    Weissler JC; Adams TN
    Lung; 2021 Dec; 199(6):589-595. PubMed ID: 34739571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.
    Pavord ID; Lettis S; Anzueto A; Barnes N
    Lancet Respir Med; 2016 Sep; 4(9):731-741. PubMed ID: 27460163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA; Cates CJ
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis.
    Luo J; Wang K; Liu D; Liang BM; Liu CT
    Respir Res; 2016 Feb; 17():18. PubMed ID: 26887407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease.
    Matkovic Z; Huerta A; Soler N; Domingo R; Gabarrús A; Torres A; Miravitlles M
    Respiration; 2012; 84(1):17-26. PubMed ID: 22327370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ICS Use May Modify FEV1 Decline in α1-Antitrypsin Deficiency Patients with Relatively High Blood Eosinophils.
    Low EV; Hughes SM; Zaffarullah S; Kantas D; Stockley RA; Turner AM
    Respiration; 2018; 95(2):114-121. PubMed ID: 29253843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort.
    Kim VL; Coombs NA; Staples KJ; Ostridge KK; Williams NP; Wootton SA; Devaster JM; Aris E; Clarke SC; Tuck AC; Bourne SC; Wilkinson TMA;
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29025891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asthma-like Features and Clinical Course of Chronic Obstructive Pulmonary Disease. An Analysis from the Hokkaido COPD Cohort Study.
    Suzuki M; Makita H; Konno S; Shimizu K; Kimura H; Kimura H; Nishimura M;
    Am J Respir Crit Care Med; 2016 Dec; 194(11):1358-1365. PubMed ID: 27224255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood biomarkers as predictors of long-term mortality in COPD.
    Mendy A; Forno E; Niyonsenga T; Gasana J
    Clin Respir J; 2018 May; 12(5):1891-1899. PubMed ID: 29227024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.
    Pavord ID; Chanez P; Criner GJ; Kerstjens HAM; Korn S; Lugogo N; Martinot JB; Sagara H; Albers FC; Bradford ES; Harris SS; Mayer B; Rubin DB; Yancey SW; Sciurba FC
    N Engl J Med; 2017 Oct; 377(17):1613-1629. PubMed ID: 28893134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.